Opportunity Information: Apply for PA 20 208

The Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) is a National Institutes of Health funding opportunity administered through the National Institute on Drug Abuse (NIDA). It is designed specifically to support doctoral candidates who are at the dissertation stage and need dedicated resources to complete an independent dissertation research project in the area of substance use and substance use disorders (SU(D)). The award provides up to two years of support, with the overall intent of helping strong trainees finish rigorous dissertation research and transition into the next stage of a research career in SU(D) science.

A key requirement is that the proposed dissertation research aligns closely with NIDA priorities. Applicants are expected to anchor their projects in NIDA's stated funding priorities and/or the NIDA Strategic Plan. In practice, that means the project should clearly connect to the scientific and public health goals that NIDA emphasizes, such as improving prevention, understanding the causes and consequences of substance use, advancing treatment and recovery science, reducing overdose and other harms, and strengthening implementation and service delivery approaches. The "clinical trials optional" designation indicates that applicants may propose research that includes a clinical trial if it is appropriate for the dissertation, but a clinical trial is not required to be competitive.

Beyond supporting individual dissertation completion, the larger program goal is workforce development. NIDA explicitly frames this mechanism as a way to bring promising new investigators into the SU(D) research field and to expand the pipeline of highly trained researchers working on substance use and addiction-related topics. Applications are particularly encouraged from candidates who would broaden and diversify the research workforce, consistent with NIH's stated interest in diversity (referenced via NOT-OD-20-031). This emphasis signals that NIDA is paying attention not only to the scientific value of the dissertation project, but also to the longer-term impact on the field's talent base and representation.

Eligibility for applicant organizations is broad and includes many types of U.S.-based institutions and entities that can serve as the sponsoring organization for a doctoral candidate. Eligible applicants listed for this opportunity include public and private institutions of higher education, state and local governments, federally recognized tribal governments, tribal organizations (including those other than federally recognized), public housing authorities/Indian housing authorities, nonprofit organizations (with and without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses, among others. The opportunity also highlights a number of institution types that are explicitly welcomed, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and U.S. territories or possessions.

At the same time, there are important restrictions related to foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components as defined by the NIH Grants Policy Statement are allowed, which generally means certain well-justified elements of the work may involve foreign collaborations or activities under NIH rules even though the primary applicant organization must be U.S.-based.

In terms of basic administrative identifiers, the funding opportunity is titled "Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional)," with Funding Opportunity Number PA 20 208. It is a discretionary grant program within the education and health activity category and is associated with CFDA number 93.279. The opportunity record shows an original closing date of 2023-05-07 and a creation date of 2020-05-08. The published excerpt does not specify an award ceiling or the expected number of awards, so those details would need to be confirmed in the full FOA or NIH guide notice, along with standard NIH requirements around dissertation status, sponsor/mentor roles, allowable costs, and submission and review procedures.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2020-05-08.
  • Applicants must submit their applications by 2023-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 20 208

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)

Previous opportunity: NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 20 208

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 20 208) also looked into and applied for these:

Funding Opportunity
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) Apply for RFA DA 21 019

Funding Number: RFA DA 21 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) Apply for PA 20 149

Funding Number: PA 20 149
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) Apply for PA 20 151

Funding Number: PA 20 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) Apply for PAR 20 221

Funding Number: PAR 20 221
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 20 225

Funding Number: PAR 20 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) Apply for PAR 20 224

Funding Number: PAR 20 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional) Apply for RFA DA 21 013

Funding Number: RFA DA 21 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) Apply for RFA CA 20 039

Funding Number: RFA CA 20 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) Apply for RFA CA 20 038

Funding Number: RFA CA 20 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) Apply for RFA DA 21 009

Funding Number: RFA DA 21 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Regional Medical Libraries for the Network of the National Library of Medicine (UG4) Apply for RFA LM 20 001

Funding Number: RFA LM 20 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) Apply for PAR 20 241

Funding Number: PAR 20 241
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) Apply for RFA CA 20 042

Funding Number: RFA CA 20 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) Apply for RFA DA 21 024

Funding Number: RFA DA 21 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) Apply for PAR 20 249

Funding Number: PAR 20 249
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Network of the National Library of Medicine Evaluation Center (U24) (Clinical Trial Not Allowed) Apply for RFA LM 20 002

Funding Number: RFA LM 20 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $610,000
Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) Apply for RFA CA 20 040

Funding Number: RFA CA 20 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) Apply for RFA CA 20 037

Funding Number: RFA CA 20 037
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed Apply for RFA DA 21 026

Funding Number: RFA DA 21 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) Apply for PAR 20 266

Funding Number: PAR 20 266
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 20 208", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: